Cargando...
Targeting the mTOR pathway in idiopathic multicentric Castleman disease
Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic illness of systemic inflammation and organ dysfunction, with unknown etiology. Although therapies targeting IL-6 have been proven effective, a subset of patients with iMCD are resistant to this approach. In this issue of the JCI,...
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763220/ https://ncbi.nlm.nih.gov/pubmed/31524635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI131332 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|